LAPATINIB DITOSYLATE vs LAROTRECTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LAPATINIB DITOSYLATE vs LAROTRECTINIB: Safety Overview
| Metric | LAPATINIB DITOSYLATE | LAROTRECTINIB |
|---|---|---|
| Total FAERS Reports | 3,948 | 798 |
| Deaths Reported | 921 | 149 |
| Death Rate | 23.3% | 18.7% |
| Hospitalizations | 752 | 151 |
| Average Patient Age | 57.3 yrs | 48.9 yrs |
| % Female Patients | 95.0% | 51.5% |
| FDA Approval Date | Aug 16, 2024 | Nov 26, 2018 |
| Manufacturer | AvKARE | Bayer HealthCare Pharmaceuticals Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |